The protozoan Giardia lamblia is a major cause of parasite-induced diarrhea in humans. Humoral immunity has been shown to be important for clearance of the infection, but only a few antigens have been identified. In this study, we focused on the immunoreactivity of nonvariant antigens. Serum samples from 93 patients with acute giardiasis who were infected during a waterborne outbreak in a nonendemic country were screened on 1-dimensional Western blots. Representative serum samples that reacted strongly with proteins of different molecular weights were further analyzed on 2-dimensional Western blots. Sixteen immunoreactive proteins were identified using mass spectrometry analysis, among them variable surface proteins, a-giardins, arginine deiminase, ornithine carbamoyl transferase, and fructose-1,6-bisphosphate aldolase. Several of the identified proteins were immunoreactive in recombinant form, and they may be important in the development of new diagnostic tools and vaccines.
host's immune system at the time of infection [1] . Humoral, as well as cellular, immunity seems to be important to clearance of the infection [2] [3] [4] . However, little is known about the mechanisms involved. It has been suggested that protective immunity occurs in humans, because adults living in areas in which Giardia is endemic have a lower prevalence of giardiasis than would be expected [5] and because the infection is self-limiting. It also has been demonstrated that hypogammaglobulinemic patients, in whom levels of IgG and IgA are decreased, often develop prolonged symptomatic giardiasis [6] . Furthermore, mice and gerbils can be protected against reinfection several months after primary infection [7, 8] . The variable surface proteins (VSPs) that cover the entire surface of the parasite are the most abundantly studied antigens in Giardia. These proteins undergo antigenic variation, and therefore their value as diagnostic and immunological targets has been questioned [9] . A few surface antigens other than VSPs have been described, among them a 66-kDa heat shock protein called the "57-kDa antigen" [10] , tubulin (55 kDa) [11] , a 49-kDa glycosylphosphatidylinositol-anchored protein [12] , several proteins between 30 and 34 kDa in size [13] [14] [15] [16] , and an 8-kDa fatty acid-binding protein [17] . A common and immunodominant antigen that could be used for serodiagnostic purposes has not yet been identified [3] .
In the present study, we analyzed serum samples from patients infected during a waterborne outbreak of giardiasis in a country in which Giardia is not endemic [18] . Approximately 3000 individuals were exposed to contaminated water after a sewage overflow into the drinking water system in the Swedish ski resort Sälen (Sälen, Sweden), and 1400 cases of giardiasis were diagnosed by fecal examination [18] . Serum samples were collected from 352 of the exposed individuals during the weeks after infection, and 145 of those individuals had cysts in their feces at the time of sampling. Indirect immunofluorescence was used to analyze the levels of specific IgG and IgA antibodies, and the results were compared with those in a control group of 428 healthy Swedish residents [18] . The antibody titers of healthy control subjects were usually low (р10), which is not surprising, because giardiasis is not endemic in Sweden and only a few citizens acquire indigenous infections every year. Thus, this is unique material; most individuals had their first infection with Giardia during a short and well-defined period, and Giardia was the only infecting pathogen. This is, to our knowledge, the first proteomics study performed for Giardia, and 16 immunoreactive proteins were identified by mass spectrometry analysis, some of which had been described in other contexts and some of which were novel.
MATERIALS AND METHODS
Reagents, cell culture, and cell differentiation. Unless otherwise indicated, reagents were obtained from Sigma Chemical. G. lamblia strain WB (ATCC 30957) clone C6, HP-88 [19] , Portland-1 (ATCC 30888), and GS (ATCC 50580) trophozoites were grown vegetatively and encysted as described elsewhere [20] .
Serum samples and indirect immunofluorescence. After an outbreak of giardiasis in Sälen, blood samples were collected from 352 persons within 3 weeks of infection [18] . Serum samples were obtained from 428 noninfected control subjects [18] : 200 healthy recruits for military service and 228 individuals who applied for work in community services. Levels of antibodies against Giardia were measured by indirect immunofluorescence, as described elsewhere [18] .
One-dimensional (1D) gel electrophoresis. One hundred micrograms of total trophozoite protein was added to 1 large lane on a 12% SDS-PAGE gel, run, and blotted to polyvinylidene fluoride membranes (Amersham Pharmacia Biotech), using a Multiphor II semidry blotter (Amersham Pharmacia Biotech). For analysis of the immunoreactivity of recombinant proteins, 3.5 mg of each protein (a-1-, a-2-, and a-7.1-giardin; ornithine carbamoyl transferase [OCT] ; and arginine deiminase [ADI]) was added to 1 large lane.
Sample preparation and 2-dimensional (2D) gel electrophoresis. Two protocols for 2D sample preparation were used, proteomics sample (PS) 1 and PS-2. The PS-1 protocol maximizes the number of proteins entering the 2D gel, somewhat to the expense of resolution. PS-2 is our standard protocol for Giardia 2D sample preparation; this protocol results in good separation and opportunities to isolate individual proteins.
In the PS-1 extraction, the sample is given an ultrasonic burst in buffer 1 (0.3% SDS, 200 mM DTT, 28 mM Tris-HCl, and 22 mM Tris-base). After boiling for 5 min, the extract is mixed with a 4-fold volume of 2D sample buffer (9.9 M urea and 4% [vol/ vol] Igepal CA630 and 2.2% [vol/vol] Pharmalytes 3-10 [both from Amersham Pharmacia Biotech]). In the PS-2 extraction, cells are sonicated in PBS supplemented with protease inhibitor cocktail (Complete Mini; Roche) and transferred to a 4-fold volume of 2D sample buffer. Cell extracts were prepared for 2D gel electrophoresis according to the PS-1 protocol (trophozoites and cytoskeleton of WB clone C6 [21] ) and the PS-2 protocol (trophozoites of WB C6, HP-88, GS, and Portland-1 and cysts of WB C6). The protein concentration in each sample was measured with a Bradford-based protein assay kit (BioRad), and samples were stored at Ϫ70ЊC until use. Isoelectric focusing was performed on a Multiphor II horizontal electrophoresis system (Amersham Pharmacia Biotech), according to the manufacturer's instructions, using 70-and 180-mm ReadyStrip IPG Strips (BioRad) with linear pH gradients of 3-10, 3-6, 5-8, and 7-10. Before loading, the protein samples were vortexed intensively, and insoluble cell debris was pelleted. Strips were loaded with 3 mg (70-mm strips) or 30 mg (180-mm strips) of protein. The second dimension was run on a 12% SDS-PAGE gel. The proteins were visualized using PlusOne silver-staining protocol (Amersham Pharmacia Biotech) or transferred to PVDF membranes. For isolation of proteins for mass spectrometric analysis, gels were loaded with 300 mg of protein and stained with Coomassie brilliant blue. Spots of interest were cut out and stored at Ϫ20ЊC until use.
Western blot analysis. 1D Western blots were incubated overnight at 4ЊC in blocking solution (2% bovine serum albumin and 1% Tween 20 in PBS) and rinsed twice before being cut into 5-mm strips containing 10 mg of total trophozoite protein or 0.35 mg of each recombinant protein per strip. The strips were probed with serum from patients infected with G. lamblia and diluted in 5 different dilutions: samples from patients with IgG titers of 320 were diluted to 1:750; from patients with titers of 160, to 1:500; from patients with titers of 80, to 1:350; from patients with titers of 40, to 1:200; and from patients with titers of 20 and control subjects, to 1:100. In total, 93 serum samples were tested. In the analysis of recombinant proteins, patient serum was diluted 1:3000 (IgG titer of 320), 1:2500 (titer of 160), 1:2000 (titer of 80), and 1: 1500 (titer of 40 and control subjects). Horseradish peroxidase-conjugated rabbit anti-human IgA (diluted 1:5000) and anti-human IgAGM (diluted 1:7500; Dako) and horseradish peroxidase-conjugated sheep anti-human IgG (1:10,000) were used as secondary antibodies. Wash steps, incubations, and detections were done according to the ECL+ manual (Amersham Pharmacia Biotech). Serum and the secondary antibodies were diluted in 0.1% Tween 20 in PBS.
In gel digestion with trypsin. In gel digestion of proteins with trypsin was performed essentially as described elsewhere [22] , with incubations at 37ЊC. Briefly, gel plugs were put into 500-mL polymerase chain reaction (PCR) tubes (Costar) and washed for 1 h in 200 mL of 0.2 M ammonium bicarbonate/ acetonitrile (1:1 vol), followed by a wash for 1 h in 200 mL of 0.05 M ammonium bicarbonate/acetonitrile (1:1 vol). Gel plugs were dried in a Speedvac (Savant) for 15 min and resoaked for 10 min in 5 mL of 0.1-mg/mL porcine modified trypsin (Promega) in 0.2 M ammonium bicarbonate, 20 mL of 0.2 M ammonium bicarbonate was added, and proteins were digested overnight. Digestions were stopped by the addition of 0.5 mL of concentrated trifluoroacetic acid (TFA), and the supernatant was collected. Peptides were extracted in stepwise manner from the gel plugs by two 1-h washes in 100 mL of 0.1% TFA in 60% acetonitrile (vol/vol). A final extraction was performed using 100 mL of 0.1% TFA in 40% acetonitrile (vol/vol), and then all 4 supernatants were pooled and concentrated in a Speedvac to 10 mL. The peptide mixes were desalted and further concentrated using reversed-phase C 18 microcolumns (ZipTip; Millipore).
Identification of proteins by mass spectrometry. Nanoelectrospray (ES) spectra were recorded on a hybrid quadrupole-orthogonal acceleration time-of-flight (TOF) tandem mass spectrometer (Micromass) fitted with an orthogonal-sampling nano-ES interface (Z-Spray; Micromass). Mass spectra were recorded at a resolution of 6000 (full width at one-half maximum height), which corresponds to ∼3000 on the 10% valley scale. The spectra were analyzed, and multiply charged peptides that were not associated with fragments of digested trypsin or known medium contaminants were subjected to tandem mass spectrometry (MS/MS) analysis. MS/MS spectra were recorded by selecting the precursor isotopic cluster of interest with the quadrupole mass filter, focusing the ions into a hexapole collision cell containing argon gas, and accelerating undissociated precursor and fragment ions into an orthogonally arranged TOF analyzer. The collision voltage used was in the range of 20-35 V. Amino acid sequence tags were generated manually and compared with translated sequences from the Giardia genome project (http://www.mbl.edu/Giardia/index2.html; Dr. M. Sogin, Marine Biological Laboratory, Woods Hole, MA), using the tblastn program (http://www.ncbi.nlm.nih.gov/BLAST/) or in Swissprot using the PeptideSearch software at the European Molecular Biology Laboratory (EMBL; http://www.mann.embl-heidelberg .de/). Matching clones were assembled into contigs, using the programs MacVector and Assembly Lign (Oxford Molecular). The predicted isoelectric point (pI), molecular weight, and monoisotopic mass of tryptic fragments for the identified openreading frame (ORF) was compared with the observed parameters, and the protein was identified.
Matrix-assisted laser desorption ionization (MALDI) mass spectrometric results were recorded with a Voyager DE-Pro instrument (PE Biosystems) and a Bruker Reflex III mass spectrometer using a-cyano-4-hydroxycinnamic acid as the matrix. The peptide mass maps were searched against simulated tryptic digests of proteins in Swissprot, using the EMBL software described above, or in GenBank, using MS-Fit (ProteinProspector; http://prospector.ucsf.edu/; University of California San Francisco).
Sequencing of genes encoding immunoreactive antigens. PCR primers were designed that amplified the complete gene from G. lamblia strain WB clone C6 genomic DNA, using Ready To Go PCR beads (Amersham Pharmacia Biotech). Primers Production of recombinant proteins. The 2 a-1-and a-2-giardin genes were amplified from G. lamblia strain WB clone C6 genomic DNA as EcoRI/BamHI fragments, using the primers A1GEX5 (5 -CCG GAT CCC CGA AGG TCA CCG ACA TTG CGA AC -3 ) and A1GEX3' (5 -GGG AAT TCT TCA CGC GCC AGA GGG TGC GAA G-3 ) for a-1-giardin and A2GEX5 (5 -CCG GAT CCC CGA AGC TAT CCC AGA TCG TCG CT- 3 ) and A2GEX3 (5 -GGG AAT TCT CCC TTA GGC GCC AGA GGG TAC A-3 ) for a-2-giardin. Platinum Taq polymerase (Life Technologies) was used in the PCR, under conditions described by the manufacturer, with denaturation at 95ЊC, annealing at 50ЊC, and extension at 72ЊC for 40 cycles. After cleavage with EcoRI and BamHI, fragments were ligated into the pGEX-6P-1 vector (Amersham Pharmacia Biotech) and transformed into Escherichia coli for screening of recombinants. Expression and purification of the glutathione S-transferase fusion proteins from the E. coli BL21 strain and the subsequent cleavage of the fusion protein with PreScission Protease (Amersham Pharmacia Biotech) was according to the pGEX manual. a-7.1-giardin, ADI, and OCT were amplified from genomic WB C6 DNA using primers A7SEX5 (5 -CGC CAT GGC TGC GGC AAA GGC TAC CGA G-3 ), A7SEX3 (5 -CGT CTA GAG CTA GCT GAC GTG CCA GAG GAC GCA GC-3 ), ARGD5 (5 -CGC CAT GGC TGA CTT CTC CAA GGA TAA AGA G-3 ), ARGD3 (5 -CGT CTA GAG CTA GCT GAT ATC GAC GCA GAT GTC AGC C-3 ), OCT5 (5 -CGC CAT GGC GTT CAA GCA GAC CCG CCA CTT GC-3 ), and OCT3 (5 -CGT CTA GAG CTA GCC CAT CTT GCA GTC ATG CAA GAA GAA G-3 ). The PCR products were cleaved with NcoI and XbaI and ligated into pProEx-HTa (Invitrogen). Proteins were overexpressed in BL21, according to the pProEx manual.
RESULTS

1D
Western blot analysis. Samples were collected from 352 exposed persons after a waterborne Giardia outbreak. Samples from the 93 individuals with the highest IgG titers (titers of 20-320) were screened by 1D Western blotting (see Methods). The antigen recognition was heterogeneous with several different reactive proteins of 20-180 kDa ( figure 1A) . The reactivity of a band at ∼30 kDa was greater in the high-titer serum samples ( figure 1A) . One patient who developed giardiasis during the study acquired a strong reactivity to the band at ∼30 kDa after the onset of the disease (figure 1B). Noninfected control subjects showed only weak reactivity with the ∼60-and ∼25-kDa bands ( figure 1A and 1B) . Only a few of the patients had high IgA levels, and samples from these patients reacted with the same protein bands when an IgA-specific secondary antibody was used (data not shown).
2D Western blot analysis. Several studies have been performed in which serum from infected patients is analyzed in 1D Western blots [13, 14, 23] . However, it is very difficult to compare these studies, because they used different isolates of Giardia, different antibody reagents, and different gel systems. So far, only 1 protein (VSP) has strictly been shown to be immunodominant in human Giardia infections [9] . To clarify this issue, we decided to identify the proteins that were most immunoreactive during an acute Giardia infection in humans. A panel of 10 high-titer serum samples with reactivity representing all bands found in the 1D Western blot analysis was screened using 2D Western blot analysis. The analysis was performed for pIs 3-10 and molecular weights 15-100 kDa, using 4 different protein extracts (see Methods). The patterns on the 2D immunoblots were compared with silver-stained 2D gels, and the reactive proteins were mapped. In total, 24 protein spots were identified as immunoreactive (labeled 1-24; figure  2 ). All spots could be detected when proteins were extracted from G. lamblia strain GS, Portland-1, and HP-88 trophozoites (data not shown). To see whether the identified proteins were expressed at all stages in the life cycle, we compared silverstained cyst 2D gels with silver-stained trophozoite 2D gels. Analysis showed that all the immunoreactive proteins identified in the trophozoite protein map could be seen at similar intensity in the cyst gel, except for spots 9, 10, 11, 16, 23, and 24 (data not shown).
Identification of immunodominant proteins by mass spectrometry. Individual spots were cut out from Coomassie brilliant blue-stained 2D gels (24 total), digested with trypsin, and analyzed by MALDI mass spectrometry and/or ES-MS/MS. N-terminal sequencing could not be performed, because 90% of the proteins were blocked in the N-terminal end (data not shown). Sequence data tags and monoisotopic mass information for the tryptic fragments are summarized in table 1. Only 1 protein was found in each spot (supplementary data may be obtained from authors on request), and most proteins were identified as proteolytic fragments or isoforms in different regions of the gel. Furthermore, we used subcellular fractions of trophozoites and isolated the spots from highly separating gels, which greatly reduces the risk of protein contamination in the picked spots. Information from mass spectrometry analysis was used to identify known Giardia proteins and to identify clones from the ongoing Giardia genome sequencing project that matched the sequence tags generated with MS/MS. Sixteen different proteins were identified as highly immunoreactive during acute giardiasis (table 1), and 6 of these were novel (SALP-1, GTA-1, GTA-2, UPL-1, a-7.1-giardin, and a-7.3-giardin). The remaining spots were proteolytic fragments or isoforms of the identified proteins.
Immunoreactivity of recombinant proteins. To verify that the identified proteins are immunoreactive, we produced recombinant protein of a-1-, a-2-, and a-7.1-giardin; OCT; and ADI ( figure 3A) . These proteins were shown to be highly immunoreactive when serum samples from G. lamblia-infected patients were tested (figure 3B). Samples from noninfected patients did not react with the recombinant proteins (figure 3B), and none of the serum samples reacted with the giardial Rab-1 protein (data not shown). This demonstrates that the identified proteins are specifically recognized by serum from patients with acute giardiasis.
DISCUSSION
In the present study, we identified immunoreactive proteins during the acute phase of giardiasis ( figure 2 and table 1 ). Several proteins with molecular weights of 20-180 kDa were NOTE. ADI, arginine deiminase; FBA, fructose-1,6-bisphosphate aldolase; GTA, Giardia trophozoite antigen; MALDI, matrix-assisted laser desorption ionization; MM, monoisotopic mass; MW, molecular weight; pI, isoelectric point; OCT, ornithine carbamoyl transferase; SALP, striated fiber-assemblin-like protein; TOF, timeof-flight; UPL, uridine phosphorylase-like protein.
a The isotopic mass for spots for which a sequence tag is given was measured by quadrupole-orthogonal acceleration TOF tandem mass spectrometry. For all others, isotopic mass was measured by MALDI-TOF mass spectrometry (change in mass !0.1 Da; no missed cleavages were allowed). b Data from 2-dimensional gel. c Sequence tags are (fragment ion mass at beginning of identified sequence)identified sequence(fragment ion mass at end of sequence). Note that the direction of the peptide sequence is not known from the mass spectrometric analysis [24] . d GenBank accession no. e Additionally confirmed by MALDI-TOF mass spectrometry. f Loss of NH 3 from carbamidomethylcysteine.
shown to be immunoreactive in the 1D Western blot analysis (figure 1). Proteins of similar molecular weights have been identified in many other 1D analyses in which samples of serum, intestinal secretions, and saliva from humans and animals were used [13, 17, 23, [25] [26] [27] [28] . However, 1D analysis with total trophozoite protein as antigen does not allow for direct identification of immunoreactive proteins, because single bands usually contain multiple comigrating proteins. In the present study, the 1D analysis was used mainly as a tool to identify serum with different specificities and to detect potential differences in the recognition patterns of serum samples with different immunoglobulin titers.
We detected reactivity in most serum samples against proteins with pIs and molecular weights similar to the predicted location of most VSPs in 2D gels (figure 2; pI, 4-5.5; molecular weight, 65-80 kDa). VSPs are cysteine-rich proteins that can undergo antigenic variation, and anti-VSP antibodies have been found in serum from humans and animals, intestinal secretions, and milk [26, 29, 30] . These proteins also reacted with monospecific antisera against the major VSP expressed in our isolate (TSA 417; data not shown). A proteolytic fragment of the semiconserved C-terminal part of TSA 417 could be identified in our 2D analysis ( figure 2, spot 24) . This fragment contains the conserved 12-aa epitope that recently has been suggested to be a cross-reactive antigenic structure of different VSPs [31] . The C-terminal part of VSPs has been shown to be glycosylated and palmitoylated [32, 33] , which may explain the poor isoelectric focusing of this spot in the gel.
a-and b-tubulin have been suggested to be among the immunodominant proteins in Giardia [11] , and they exist as multiple isoforms with pIs of 4-5.5 and molecular weights of 54-58 kDa [21] . In the 2D analysis, several spots were shown to be derived from a-and b-tubulin ( figure 2, spots 2, 3, 6, and 9) . Thus, VSPs and a-and b-tubulin are major antigens in acute Giardia infections, but their usefulness in diagnosis and vaccine development is limited due to antigenic variation (VSPs) and lack of specificity (tubulin). We decided to focus on proteins other than VSPs and tubulin, because Giardia-specific, invariable, highly immunogenic proteins are interesting in diagnosis and vaccine development.
Two new genes with no homologies to known proteins were identified at spots 1 and 18 (figure 2). Spot 1, GTA-1, has an SAM (sterile a motif) region [34] . SAM is an evolutionarily conserved protein-binding domain that is involved in the regulation of numerous developmental processes in diverse eukaryotes, and it can often be found in proteins involved in signal transduction. This spot, which has a molecular weight of 21 kDa and a pI of 5.2, was recognized by serum from only a few patients in the 2D analysis. Spot 18, GTA-2, was recognized by serum from all patients tested in the 2D analysis. The expression of this protein was constant throughout the entire life cycle. Spots 4 and 5 (figure 2) are b-giardin, an adhesive discspecific protein that has been suggested to be surface exposed in G. muris [35] . The adhesive disc, in which b-giardin is a structural protein, is closely associated with the intestinal epithelial cells and plays an important role in the host-parasite interaction [36] .
Spot 7 (figure 2) is a new protein that is homologous to SFassemblin, a protein associated with basal bodies in flagellated protozoa [37] . This protein, SALP-1, was enriched in the cytoskeleton preparation, but we do not currently know where it is localized in the cell. Spot 8 is enolase, which has been shown to be an important antigen in many other medically important microbes [38] . The protein is secreted from many of these microbes, but its role in infection is not known.
Giardia incorporates exogenous pyrimidine nucleobases, and uridine is cleaved via the phosphorolytic activity of the phosphate-dependent enzyme uridine/thymidine phosphorylase [39] . Spot 19 (figure 2), UPL-1, was shown to be similar to uridine/thymidine phosphorylase. Drugs that inhibit uridine phosphorylase have been shown to be effective against Giardia [40] , and this enzyme may be a future drug target.
Spot 20 (figure 2) is fructose-1,6-bisphosphate aldolase, a glycolytic enzyme that catalyzes the cleavage of fructose-1,6-bisphosphate into 2 triose sugars, glyceraldehyde 3-phosphate and dihydroacetone phosphate. Fructose-1,6-bisphosphate aldolase was identified by immunoscreening with hyperimmune serum from patients infected by Onchocerca volvulus [41] and Schistosoma mansoni [42] , 2 helminth parasites of great medical importance. An analysis of the serologic response to systemic Candida albicans infection in a murine model identified fructose-1,6-bisphosphate aldolase as one of 31 immunoreactive proteins [43] . Another study showed the presence of antibodies against Plasmodium falciparum fructose-1,6-bisphosphate aldolase in serum samples from human adults with partial immunity to malaria [44] .
Giardia can use arginine as an energy source via the arginine dihydrolase pathway, in which substrate-level phosphorylation produces 1 ATP molecule from 1 molecule of arginine [45] . The 2 first steps of this 3-step pathway are catalyzed by ADI and OCT, and these 2 proteins were shown to be among the immunodominant proteins in Giardia (figure 2). The intestinal epithelium secretes nitric oxide (NO) as a defense mechanism against microbes [3, 46] . NO is produced enzymatically from arginine through the action of NO synthase. It has recently been shown that Giardia can block the synthesis of NO by human intestinal epithelial cells by consuming arginine, and ADI and OCT can be important in this process [47] . Several spots of both enzymes were found, and these correspond to proteolytic fragments of the mature proteins. These fragments, as well as other proteolytic fragments, disappear during encystation, which may indicate that proteolytic activity is reduced when the cells encyst.
The 1D analysis showed that serum samples from patients with high IgG titers mainly react with an antigen of ∼30 kDa (figure 1). A similar-sized antigen has been identified in several other investigations [13] [14] [15] [16] [48] [49] [50] and is present in trophozoites and cysts. It has been suggested that this protein is a-1-giardin [16] , a protein that was originally identified as an adhesive disc protein, but this has never been proven. Analysis on 2D gels was needed to identify the 30-kDa band, because the region at ∼29-35 kDa contains the bulk of Giardia proteins (figure 2). Our results show that the 30-kDa antigen is a-1-giardin ( figure 2, spot 17) , but the homologue, a-2-giardin ( figure 2, spots 12 and 15) , is also reactive. Serum from a patient who developed giardiasis during the investigation reacted strongly with a-1-giardin in 1D/2D Western blot analysis (figure 1B; data not shown). We also identified 2 new immunoreactive members of the a-giardin gene family, which we named "a-7.1-giardin" and "a-7.3-giardin." One more a-giardin (a-7.2-giardin), which was almost identical to a-7.1-giardin, was found in the Giardia genome. Currently, we do not know the function of these new a-giardins. All the a-giardins were expressed constantly throughout the life cycle of the parasite.
Several new immunoreactive proteins were identified in the present study that may be important in the development of new diagnostic tools and vaccines. Recently, a Giardia veterinary vaccine has become commercially available for use in dogs and cats [51] . This vaccine is composed of disrupted trophozoites and results in protection and decreased cyst shedding in kittens and puppies. However, a subunit vaccine would be the preferred choice. The recombinant forms of several of the immunoreactive proteins are recognized by serum from infected human patients (figure 3). Our identified, nonvariant immunoreactive recombinant proteins are potential targets in trials in which purified antigens are used as components in a multivalent vaccine. The a-giardins are Giardia-specific proteins, and our results show that anti-Giardia IgG titers in serum from patients with acute giardiasis could be correlated to recombinant a-giardin immunoreactivity ( figure 3) . This makes the agiardins interesting in the development of new methods for diagnosis of giardiasis. Treatment of infected patients quickly reduced antibody titers, but treatment failure or chronic infection/reinfection resulted in higher antibody titers (40-320; data not shown). This shows that serologic testing could be a useful complement in the diagnosis of giardiasis in such patients. Waterborne outbreaks of giardiasis are almost always investigated retrospectively [18, 52] , and many patients either have cleared the infection or have been treated when the investigation starts. Symptomatology and fecal examinations are, therefore, not useful, but serologic evidence of a recent infection can be useful in a country where the population immunity to Giardia infection is low.
